Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Molecular Partners price target lowered to $4 from $4.50 at JPMorgan
26d ago
MOLN
Premium
Ratings
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
1M ago
MOLN
Premium
Ratings
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
1M ago
MOLN
Premium
Company Announcements
Molecular Partners Reports H1 2025 Progress and Financial Stability
1M ago
Premium
Ratings
Molecular Partners’ Promising Pipeline and Strategic Advancements Justify Buy Rating
1M ago
MOLN
Premium
The Fly
Molecular Partners appoints Martin Steegmaier as chief scientific officer
1M ago
MOLN
Premium
Ratings
Molecular Partners’ Promising Oncology Developments and Strategic Focus Earn Buy Rating
3M ago
MOLN
Premium
Ratings
Buy Recommendation for Molecular Partners: Promising MP0533 Study Results and Strategic Developments
4M ago
MOLN
Premium
The Fly
Molecular Partners to preent updated data from MP0533 trial at EHA congress
4M ago
MOLN
Premium
Ratings
Molecular Partners: Strategic Restructuring and Financial Stability Drive Buy Rating
4M ago
MOLN
Premium
The Fly
Molecular Partners to reduce workforce by 24%
4M ago
MOLN
Premium
Ratings
Molecular Partners’ Strategic Advancements and Promising Pipeline Drive Buy Rating
4M ago
MOLN
Premium
Ratings
Molecular Partners’ Promising MP0533 Program Drives Buy Recommendation
5M ago
MOLN
Premium
The Fly
Molecular Partners presents new data on Radio-DARPin, Switch-DARPin programs
5M ago
MOLN
Premium
Ratings
Molecular Partners: Strategic Positioning and Innovative Platforms Drive Buy Rating in Oncology Space
7M ago
MOLN
Premium
The Fly
Molecular Partners initiated with an Outperform at LifeSci Capital
7M ago
MOLN
Premium
Company Announcements
Molecular Partners’ Earnings Call: Progress Amid Challenges
7M ago
Premium
Ratings
Molecular Partners AG: Strong Financials and Promising Pipeline Justify Buy Rating
7M ago
MOLN
Premium
Company Announcements
Molecular Partners Reports 2024 Earnings and Strategic Progress
7M ago
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
